Baird Maintains Outperform on Healthpeak Properties, Lowers Price Target to $19
Benzinga Newsdesk 7 months ago
NewsPrice TargetAnalyst Ratings
Baird analyst Amanda Sweitzer maintains Healthpeak Properties (NYSE:DOC) with a Outperform and lowers the price target from $20 to $19.
Baird analyst Amanda Sweitzer maintains Healthpeak Properties (NYSE:DOC) with a Outperform and lowers the price target from $20 to $19.